Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Medplus Health Servi

₹701.4 15.2 | 2.2%

Market Cap ₹8384 Cr.

Stock P/E 142.7

P/B 5.4

Current Price ₹701.4

Book Value ₹ 128.9

Face Value 2

52W High ₹977.5

Dividend Yield 0%

52W Low ₹ 598

Medplus Health Servi Research see more...

Overview Inc. Year: 2006Industry: Pharmaceuticals & Drugs

MedPlus Health Services Ltd engages in the retail buying and selling of medicines and general items in India. It offers pharmaceutical and wellbeing products, including medicines, vitamins, medical gadgets, and test kits; fast-shifting customer goods, such as toiletries, infant care products, soaps, detergents, and sanitizers. The organisation additionally offers wholesale cash and carry, and pathological laboratory testing offerings, in addition to engages within the settlement manufacturing of private label prescribed drugs. As of March 31, 2021, it operated thru 1,659 shops in the states of Karnataka, Tamil Nadu, Telangana, and Andhra Pradesh, as well as via its online shop. The enterprise was founded in 2006 and is based in Hyderabad, India.

Read More..

Medplus Health Servi Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Medplus Health Servi Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 925 933 966 994 1121 1190 1253 1284 1409 1441
Other Income 7 7 13 10 11 11 14 9 10 10
Total Income 932 941 979 1004 1132 1202 1267 1294 1419 1451
Total Expenditure 863 872 914 941 1061 1119 1171 1213 1323 1350
Operating Profit 69 69 65 63 71 83 95 81 95 102
Interest 16 17 19 20 20 21 22 23 24 24
Depreciation 28 30 34 38 42 46 56 52 55 57
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 25 22 13 5 9 16 17 5 16 20
Provision for Tax 5 5 1 1 2 3 -9 1 2 6
Profit After Tax 20 17 11 4 6 13 27 4 15 14
Adjustments 0 0 0 -0 0 0 0 0 0 0
Profit After Adjustments 20 17 12 3 7 13 27 4 15 14
Adjusted Earnings Per Share 6.3 1.4 1 0.3 0.6 1.1 2.2 0.3 1.2 1.1

Medplus Health Servi Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 1368 1733 2011 2132 2273 2871 3069 3779 4558 5387
Other Income 4 9 8 7 10 17 22 31 46 43
Total Income 1373 1742 2020 2139 2283 2888 3091 3811 4604 5431
Total Expenditure 1333 1691 1935 2073 2216 2737 2840 3490 4276 5057
Operating Profit 40 50 85 66 67 151 251 320 327 373
Interest 17 22 25 28 16 47 67 83 99 93
Depreciation 9 10 11 12 14 75 88 119 182 220
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 14 19 48 26 37 29 95 118 47 58
Provision for Tax 6 10 19 -17 16 28 32 23 -3 0
Profit After Tax 7 9 29 42 21 2 63 95 50 60
Adjustments 0 -0 -0 0 0 0 1 1 -0 0
Profit After Adjustments 7 9 29 42 21 2 64 96 50 60
Adjusted Earnings Per Share 39.4 47.8 152.3 194.1 95.8 8.2 285.1 8 4.2 4.8

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 21% 17% 16% 0%
Operating Profit CAGR 2% 29% 38% 0%
PAT CAGR -47% 192% 4% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -7% NA% NA% NA%
ROE Average 4% 8% 6% 9%
ROCE Average 10% 16% 15% 14%

Medplus Health Servi Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 154 149 160 303 325 528 731 1418 1491
Minority's Interest 0 0 0 0 0 1 1 -1 -1
Borrowings 62 65 54 8 0 0 0 0 0
Other Non-Current Liabilities 5 18 34 -27 10 327 399 647 797
Total Current Liabilities 210 269 276 325 337 498 445 559 477
Total Liabilities 430 501 525 610 672 1354 1575 2624 2764
Fixed Assets 67 77 81 83 90 419 517 799 1138
Other Non-Current Assets 46 48 49 69 107 102 105 193 146
Total Current Assets 317 376 395 458 475 833 953 1632 1481
Total Assets 430 501 525 610 672 1354 1575 2624 2764

Medplus Health Servi Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 13 46 31 21 35 -47 9 -28 -121
Cash Flow from Operating Activities -19 -17 34 32 82 -7 3 170 90
Cash Flow from Investing Activities -15 -32 -15 -18 -20 -28 -35 -703 429
Cash Flow from Financing Activities 66 35 -29 -1 -72 90 -6 440 -170
Net Cash Inflow / Outflow 32 -15 -10 14 -10 56 -37 -93 350
Closing Cash & Cash Equivalent 45 31 21 35 24 9 -28 -121 228

Medplus Health Servi Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 39.43 47.84 152.33 194.06 95.77 8.22 285.08 8.03 4.17
CEPS(Rs) 85.43 100.33 212.89 251.21 159.72 350.98 675.81 17.94 19.42
DPS(Rs) 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 716.21 694.75 752.08 1363.1 1450.49 2378.5 3044.19 117.89 122.44
Core EBITDA Margin(%) 2.61 2.39 3.81 2.75 2.5 4.65 7.32 7.54 6.08
EBIT Margin(%) 2.28 2.33 3.65 2.5 2.32 2.65 5.19 5.24 3.15
Pre Tax Margin(%) 1.01 1.08 2.38 1.2 1.61 1.02 3.04 3.08 1.02
PAT Margin (%) 0.55 0.52 1.43 1.99 0.92 0.06 2.01 2.47 1.08
Cash Profit Margin (%) 1.18 1.1 2 2.57 1.53 2.67 4.83 5.59 5.01
ROA(%) 1.73 1.94 5.62 7.47 3.26 0.18 4.31 4.51 1.86
ROE(%) 5.51 6.78 21.06 19.26 6.81 0.43 10.51 9.07 3.5
ROCE(%) 10.02 12.04 20.61 13.06 11.77 14.34 21.69 16.56 9.56
Receivable days 1.03 0.77 0.53 1.09 1.53 0.96 0.69 0.54 0.58
Inventory Days 67.6 59.37 58.51 59.74 60.81 65.93 81.18 79.28 81.27
Payable days 34.09 28.02 24.9 25.21 28.85 31 28.76 24.13 25.98
PER(x) 0 0 0 0 0 0 0 125.8 156.11
Price/Book(x) 0 0 0 0 0 0 0 8.57 5.32
Dividend Yield(%) 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.09 0.1 0.08 0.05 0.02 -0.01 0.01 3.22 1.64
EV/Core EBITDA(x) 3.07 3.44 1.92 1.59 0.82 -0.23 0.07 37.97 22.86
Net Sales Growth(%) 0 26.64 16.07 5.99 6.61 26.31 6.92 23.13 20.59
EBIT Growth(%) 0 29.35 81.5 -27.21 -1.32 44.56 113.38 23.63 -27.38
PAT Growth(%) 0 21.32 218.43 46.9 -50.65 -91.42 3417.89 50.08 -47.1
EPS Growth(%) 0 21.31 218.43 27.39 -50.65 -91.42 3368.17 -97.18 -48.06
Debt/Equity(x) 1.07 1.46 1.24 0.55 0.33 0.2 0.2 0.1 0
Current Ratio(x) 1.51 1.4 1.43 1.41 1.41 1.67 2.14 2.92 3.11
Quick Ratio(x) 0.3 0.25 0.22 0.29 0.24 0.38 0.46 1.28 0.71
Interest Cover(x) 1.79 1.86 2.89 1.92 3.27 1.63 2.41 2.42 1.48
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0.01 0

Medplus Health Servi Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 40.43 40.43 40.43 40.43 40.43 40.43 40.43 40.41 40.45 40.39
FII 3.42 2.97 3.15 3.74 3.95 4.49 4.86 12.36 12.97 14.94
DII 27.72 29.24 29.48 28.84 28.77 28.16 28.14 25.49 25.18 22.47
Public 28.43 27.36 26.94 26.99 26.85 26.93 26.57 21.74 21.4 22.2
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company is almost debt free.

Cons

  • Promoter holding is low: 40.39%.
  • Company has a low return on equity of 8% over the last 3 years.
  • Debtor days have increased from 24.13 to 25.98days.
  • Stock is trading at 5.4 times its book value.
  • The company has delivered a poor profit growth of 3% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Medplus Health Servi News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....